Medtronic Plc

Research Medtronic Plc (MDT) on Bullrun: valuation model: 17.6% undervalued, market cap USD 103.60B, P/E 21.7, dividend yield 1.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMDT
• ExchangeNYSE
• CountryIreland
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Valuation signal17.6% undervalued
• Market capUSD 103.60B
• P/E21.7
• Dividend yield1.8%
• Financial periodFY2025
• RevenueUSD 33.54B
• Revenue growth3.6%
• Net incomeUSD 4.66B
• Free cash flowUSD 5.19B
• Gross margin65.3%

Valuation Snapshot

Bullrun's latest valuation model marks Medtronic Plc as 17.6% undervalued; latest market cap is USD 103.60B; P/E is 21.7; dividend yield is 1.8%.

About Medtronic Plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products;

Frequently asked questions

Is Medtronic Plc overvalued or undervalued?

Bullrun's valuation model currently marks Medtronic Plc as 17.6% undervalued.

What is Medtronic Plc's market cap?

Medtronic Plc's market capitalization is USD 103.60B.

What is Medtronic Plc's P/E ratio?

Medtronic Plc's price-to-earnings (P/E) ratio is 21.7.

Does Medtronic Plc pay a dividend?

Medtronic Plc has a dividend yield of 1.8%.

What does Medtronic Plc do?

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.